New
HealthMore in Health→
Levetiracetam Shows Therapeutic Action at GABAergic Synapses in Diffuse Midline Glioma
Key Takeaways
- Nature Medicine published the study online on 17 September 2026 under DOI 10.1038/s41591-026-04646-6.
- The paper reports that levetiracetam, described as an antiseizure medication, therapeutically targets GABAergic synapses in diffuse midline glioma.
- Evidence comes from experimental models and from data drawn from patient cohorts.
- Diffuse midline gliomas are infiltrative tumors in midline structures, making surgery and localized treatment difficult.
DE
DT Editorial Team··via nature.com